Shenzhen Liying Biotechnology Co., Ltd announced that it has received in Angel+ round of funding on May 24, 2024. The transaction included participation from returning investors Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, and Wuxi Best Precision Machinery Co., Ltd. and other institutions such Dandelion (Shenzhen) Pharmaceutical Venture Capital Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.8 CNY | -5.20% | +9.22% | -6.63% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
32.8 CNY | -5.20% | +9.22% | 1.03B | ||
26.31 CNY | -3.20% | -5.02% | 1.24B | ||
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.63% | 1.03B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 002880 Stock
- News Shenzhen Weiguang Biological Products Co., Ltd.
- Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors